Skip to main content
. 2014 Jul 23;1(4):133–139. doi: 10.1016/j.jcte.2014.07.001

Table 1.

Comparison of clinical features and biochemical criterion between each group

Clinical indexes Group A Group B1 Group B2 Group C P-value
Case (n) (proportion) 623 (22.56%) 697 (25.24%) 270 (9.78%) 1171 (42.41%)
M:F 183:440 463:234 231:39 703:468 <0.001
Age (year)a 36.70 ± 11.82 48.97 ± 12.09 42.07 ± 12.01 45.29 ± 14.75 <0.001
Weight (kg)a 56.21 ± 7.31 72.73 ± 10.50 79.56 ± 11.71 65.44 ± 10.16 <0.001
Ma 62.49 ± 7.06 76.89 ± 8.96 81.20 ± 11.09 70.11 ± 8.74 <0.001
Fa 53.59 ± 5.62 64.43 ± 8.17 69.91 ± 10.65 58.40 ± 7.84 <0.001
BMI (kg/m2)a 20.92 ± 1.84 26.29 ± 2.83 27.70 ± 3.27 23.77 ± 2.65 <0.001
NC (cm)a 32.60 ± 2.37 37.21 ± 3.06 38.94 ± 2.62 35.33 ± 3.03 <0.001
Ma 35.34 ± 1.90 38.75 ± 2.17 39.46 ± 2.20 37.11 ± 2.09 <0.001
Fa 31.46 ± 1.42 34.17 ± 2.15 35.86 ± 2.78 32.65 ± 2.12 <0.001
NHtRa 0.20 ± 0.01 0.22 ± 0.02 0.23 ± 0.01 0.21 ± 0.02 <0.001
Ma 0.21 ± 0.01 0.23 ± 0.01 0.23 ± 0.01 0.22 ± 0.01 <0.001
Fa 0.19 ± 0.01 0.22 ± 0.01 0.23 ± 0.02 0.21 ± 0.01 <0.001
NWtRb 0.59 ± 0.05 0.52 ± 0.05 0.50 ± 0.06 0.54 ± 0.06 <0.001
M 0.57 ± 0.05 0.51 ± 0.05 0.49 ± 0.05 0.54 ± 0.05 <0.001
F 0.59 ± 0.05 0.54 ± 0.05 0.53 ± 0.05 0.57 ± 0.06 <0.001
WC (cm) Ma 77.78 ± 6.63 93.44 ± 7.50 96.34 ± 7.51 85.74 ± 7.59 <0.001
Fa 71.40 ± 5.52 85.47 ± 7.74 90.14 ± 9.47 78.38 ± 7.74 <0.001
WHRa 0.79 ± 0.06 0.92 ± 0.07 0.94 ± 0.06 0.86 ± 0.07 <0.001
Ma 0.83 ± 0.06 0.93 ± 0.06 0.95 ± 0.05 0.88 ± 0.06 <0.001
Fa 0.77 ± 0.05 0.88 ± 0.06 0.91 ± 0.06 0.83 ± 0.06 <0.001
ALT (U/L)a 15.65 ± 10.77 24.22 ± 7.95 66.26 ± 30.16 21.38 ± 12.19 <0.001
HbA1c (%)b 5.23 ± 0.53 5.58 ± 1.08 6.18 ± 1.36 5.44 ± 0.76 <0.001
FINS (μIU/ml)a 18.68 ± 8.43 26.51 ± 13.59 33.7 ± 19.17 20.92 ± 9.31 <0.001
FCP (ng/ml)a 2.55 ± 0.93 3.79 ± 1.43 4.51 ± 1.62 3.01 ± 1.25 <0.001
HOMA-IRa 1.18 ± 1.99 6.85 ± 5.12 9.17 ± 7.50 5.05 ± 3.07 <0.001
QUICKI 1.15 ± 0.13 0.98 ± 0.14 0.91 ± 0.15 1.08 ± 0.14 <0.001

Group A, healthy subjects; Group B, NAFLD subjects; Group B1, subjects without elevated ALT; Group B2, subjects with elevated ALT; Group C, subjects with other metabolic disturbances.

a

Differences are statistically significant between each group in four groups (P < 0.05).

b

Differences are no statistically significant between group B1 and B2 (P > 0.05).